Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.77%
1,097.81
-8.55
-0.77%
1,106.361,105.681,109.291,096.52
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
612.03
+1.74
+0.29%
610.29610.29616.60610.29
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.43
+9.21
+0.76%
1,211.221,211.011,222.361,208.50
SIXI
Industrials
SIXI
Industrials
SIXI
+0.50%
1,759.52
+8.81
+0.50%
1,750.711,753.101,762.131,743.30
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
631.54
+3.37
+0.54%
628.17629.38634.09629.38
SIXR
Staples
SIXR
Staples
SIXR
+0.30%
857.16
+2.59
+0.30%
854.57855.71860.09855.45
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
215.41
-1.46
-0.67%
216.87216.87217.79215.29
SIXT
Technology
SIXT
Technology
SIXT
+1.47%
3,614.15
+52.21
+1.47%
3,561.943,571.443,628.583,562.15
SIXU
Utilities
SIXU
Utilities
SIXU
+0.55%
908.30
+4.99
+0.55%
903.31903.26908.38901.18
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.40
-1.14
-0.08%
1,481.541,482.481,488.461,474.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.07%
2,398.37
-1.58
-0.07%
2,399.952,404.452,418.812,396.04
CHRS:NASDAQ
Coherus Oncology Inc
$1.63
-4.40%
(-0.075) 1D
$1.65
+1.21% (+0.020)
After hours
Closed: May 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
$1.70
High
$1.74
Low
$1.62
Mkt. cap
250.69M
Avg. vol.
1.16M
Volume
1.98M
P/E ratio
0.98
52-wk high
$2.62
52-wk low
$0.71
EPS
$1.67
Beta
1.01
Shares outstanding
154.25M
No. of employees
145
News stories
From sources across the web
About Coherus Oncology Inc
CEODennis Lanfear
Employees145
Founded2010
HeadquartersRedwood City, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.25M
11.57M
12.75M
12.31M
Cost of goods sold
3.40M
3.72M
4.04M
3.81M
Cost of revenue
3.40M
3.72M
4.04M
3.81M
Research and development expenses
26.31M
27.25M
30.97M
21.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.04M
22.83M
21.01M
23.10M
Operating expense
52.34M
50.08M
51.98M
44.65M
Total operating expenses
55.74M
53.80M
56.03M
48.46M
Operating income
-45.49M
-42.23M
-43.28M
-36.15M
Other non operating income
2.90M
2.14M
-5.22M
1.40M
EBT including unusual items
-44.86M
-44.52M
-46.35M
-36.94M
EBT excluding unusual items
-44.86M
-42.42M
-43.75M
-36.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
297.77M
-35.53M
-37.64M
-38.33M
Net profit margin
2,903.91%
-307.07%
-295.29%
-311.35%
Earnings per share
-0.34
-0.33
-0.34
-0.25
Interest and investment income
-
-
7.00M
-
Interest expense
-2.28M
-2.32M
-2.25M
-2.19M
Net interest expenses
-2.28M
-2.32M
4.75M
-2.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.47M
-41.27M
-42.38M
-35.17M
Gain or loss from assets sale
-
-
-338.32M
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more